One thing interesting is that c-Met inhibitors induced G1/S arrest in c-Met-addicted cells (Fig. 4) All of the successful agents for cancer targeted therapy, such as imatinib, sorafenib and gefitinib, have shown strong G1/S arrest to result in apoptosis [39–41]. This evidence concerns the gene MET and cancer.